Minimum Investment
About Company
Company Name: Pramodini Medicare Limited
Industry / Sector: Healthcare - Diagnostic Services (Radiology, Clinical Laboratory & Nuclear Medicine)
Founded Year: 2000
Promoters: Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumar, Sri Ram Medicare Pvt. Ltd.
Pramodini Medicare is a diagnostic service provider offering technology-enabled services across radiology (MRI, CT, X-ray, ultrasound, mammography, Dexa, interventional radiology), clinical laboratory (haematology, microbiology, immunology, pathology, biochemistry) and nuclear medicine (PET-CT, SPECT, nuclear therapy). It operates through PPP with government hospitals, private-private partnerships, PSU collaborations and standalone centres. As of August 2026 it operates 16 diagnostic centres across seven states and runs a 24×7 teleradiology unit from Vijayawada.
IPO Basic Details
| Company Name | Pramodini Medicare Limited |
| IPO Type | SME IPO |
| Price Band | ₹110 – ₹118 |
| Lot Size | 1,200 Shares |
| Total Issue Size | 58,51,200 Equity Shares (₹69.04 Cr) |
IPO Strengths & Risks
Strengths
- Strategic presence across multiple states
- Diversified business models (PPP, Pvt-Pvt, PSU, Standalone)
- Strong technical capabilities and IT infrastructure
- Experienced management team
- Consistent revenue and profit growth
- Diverse customer base
Risks
- Dependence on partnerships and contracts with hospitals/PSUs
- Competition in diagnostic services sector
- Capital intensive nature of medical equipment
- Regulatory and compliance risks in healthcare
IPO Important Dates
| IPO Open Date | 12 Aug 2026 |
| IPO Close Date | 14 Aug 2026 |
| Basis of Allotment | 17 Aug 2026 |
| Refund Initiation | 18 Aug 2026 |
| Demat Credit Date | 18 Aug 2026 |
| Listing Date | 19 Aug 2026 |
| Anchor Investor Date | - |
| UPI Mandate Deadline | - |
IPO Objectives
- Capital expenditure for machinery and equipment – -
- Funding working capital requirements – -
- Debt repayment – -
- General corporate purposes – -
Investor Reservation
| QIB Quota | 45.91% of Net Issue |
| Retail Quota | 36.68% of Net Issue |
| HNI Quota | - |
| Employee Quota | - |
| Shareholder Quota | - |
| Anchor Investor Allocation | - |
Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lots | 2,400 | ₹2,83,200 |
| Retail Maximum | - | - | - |
| S-HNI Minimum | 3 Lots | 3,600 | ₹4,24,800 |
| S-HNI Maximum | - | - | - |
| B-HNI Minimum | 8 Lots | 9,600 | ₹11,32,800 |
Key Performance Indicators (KPI)
| ROE | 39.08% (Mar 2026) |
| ROCE | 34.66% (Mar 2026) |
| RoNW | 32.69% (Mar 2026) |
| PAT Margin | 27.90% (Mar 2026) |
| EBITDA Margin | 49.61% (Mar 2026) |
| EPS | - |
| NAV per share | - |
| Debt to Equity | 0.34 (Mar 2026) |
| P/E Ratio | - |
| Industry P/E | - |
Company Financial Data
| Period | Assets | Total Income | PAT | EBITDA | Net Worth | Borrowings |
|---|---|---|---|---|---|---|
| FY2026 (31 Mar 2026) | ₹93.62 Cr | ₹63.38 Cr | ₹17.38 Cr | ₹30.90 Cr | ₹53.15 Cr | ₹17.85 Cr |
| FY2025 (31 Mar 2025) | ₹56.45 Cr | ₹38.55 Cr | ₹11.14 Cr | ₹20.97 Cr | ₹35.77 Cr | ₹10.81 Cr |
| FY2024 (31 Mar 2024) | ₹48.78 Cr | ₹35.79 Cr | ₹7.14 Cr | ₹15.53 Cr | ₹24.75 Cr | ₹11.96 Cr |
Grey Market Premium
| GMP Price | Not Available |
| Kostak Rate | Not Available |
| Subject to Sauda | Not Available |
| Last Updated | Aug 2026 |
| Estimated Listing Price | TBA |
IPO Subscription Data
| Total Subscription | Pending |
| QIB (Ex Anchor) | Pending |
| HNI Subscription | Pending |
| Retail Subscription | Pending |
| Anchor | - |
IPO Intermediaries
Registrar: Purva Sharegistry (India) Pvt. Ltd.
Registrar Website: https://www.purvashare.com/investor-service/ipo-query
IPO Lead Manager(s)
Company Information
Address: D. No: 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada, Andhra Pradesh 520002
Website: https://www.pramodinidiagnostics.com/
Email: investors@pramodinidiagnostics.com
Phone: +91 9985782727
IPO Documents
Frequently Asked Questions (FAQ)
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.